missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cytiva MabSelect Sure™ LX Chromatography Media
Protein A affinity medium with high dynamic binding capacity which improves performance and cuts costs
Brand: Cytiva 17-5474-01
This item is not returnable.
View return policy
Description
Alkali tolerance allows for stability, thorough cleaning and reduction in contamination
- Alkali-stabilized Protein A-derived (E.coli) Ligand
- High dynamic binding capacity (DBC) for high titer cultures
- Reduces risk of contamination and carryover
- Alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH
Purification of monoclonal antibodies for clinical applications and process scale
Certifications
Certificate of Analysis
Specifications
| 25 mL | |
| For PurifiCatIon of Monoclonal Antibodies for Clinical AppliCatIons | |
| 60 mg Human IgG/mL mediμm | |
| 500 cm/Hoμr | |
| 7.87 in. | |
| Certificate of Analysis | |
| Highly Cross-Linked Agarose | |
| 20% Ethanol |
| Stable in aqueous Buffers commonly used in Protein A Chromatography | |
| 2°C to 8°C | |
| MabSelect SuRe LX Media | |
| 85 μm | |
| 20 cm | |
| <2 bar | |
| 3 to 12 | |
| Alkali-stabilized Protein A-derived (E. coli) |
Safety and Handling
Product Identifier
Signal Word
Hazard Category
Hazard Statement
Precautionary Statement
Supplemental information
- MabSelect SuRe LX, 25 ml
Signal Word
- Warning
Hazard Category
- Flammable liquid Category 3
Hazard Statement
- H226-Flammable liquid and vapour.
Precautionary Statement
- P241-Use explosion-proof electrical/ventilating/lighting/ equipment.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental information
- MIXTURE LIST-Contains : ethanol
- UNKNOWN ACUTE-16.5 per cent of the mixture consists of component(s) of unknown acute toxicity.
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction